| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PIK-93 | GDSC1000 | pan-cancer | AAC | 0.038 | 0.2 |
| mRNA | AS605240 | GDSC1000 | pan-cancer | AAC | 0.043 | 0.2 |
| mRNA | HG-5-113-01 | GDSC1000 | pan-cancer | AAC | 0.06 | 0.2 |
| mRNA | selumetinib:BRD-A02303741 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.059 | 0.2 |
| mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | -0.068 | 0.2 |
| mRNA | GSK2126458 | GDSC1000 | pan-cancer | AAC | 0.041 | 0.2 |
| mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | methylstat | CTRPv2 | pan-cancer | AAC | 0.052 | 0.2 |